Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2024 Jun 26;16(7):1031.
doi: 10.3390/v16071031.

Comparative Analysis of the Clinical Presentation of Individuals Who Test Positive or Negative for SARS-CoV-2: Results from a Test Street Study

Affiliations
Comparative Study

Comparative Analysis of the Clinical Presentation of Individuals Who Test Positive or Negative for SARS-CoV-2: Results from a Test Street Study

Pantea Kiani et al. Viruses. .

Abstract

The common cold, the flu, and the 2019 coronavirus disease (COVID-19) have many symptoms in common. As such, without testing for severe-acute-respiratory-syndrome-related coronavirus 2 (SARS-CoV-2), it is difficult to conclude whether or not one is infected with SARS-CoV-2. The aim of the current study was to compare the presence and severity of COVID-19-related symptoms among those who tested positive or negative for the beta variant of SARS-CoV-2 (B.1.351) and identify the clinical presentation with the greatest likelihood of testing positive for SARS-CoV-2. n = 925 individuals that were tested for SARS-CoV-2 at Dutch mass testing sites (i.e., test streets) were invited to complete a short online survey. The presence and severity of 17 COVID-19-related symptoms were assessed. In addition, mood, health correlates, and quality of life were assessed for the week before the test. Of the sample, n = 88 tested positive and n = 837 tested negative for SARS-CoV-2. Individuals who tested positive for SARS-CoV-2 reported experiencing a significantly greater number, as well as greater overall symptom severity, compared to individuals who tested negative for SARS-CoV-2. A binary logistic regression analysis revealed that increased severity levels of congestion, coughing, shivering, or loss of smell were associated with an increase in the odds of testing positive for SARS-CoV-2, whereas an increase in the severity levels of runny nose, sore throat, or fatigue were associated with an increase in the odds of testing negative for SARS-CoV-2. No significant differences in mood or health correlates were found between those who tested positive or negative for SARS-CoV-2, except for a significantly higher stress score among those who tested negative for SARS-CoV-2. In conclusion, individuals that tested positive for SARS-CoV-2 experienced a significantly greater number and more severe COVID-19-related symptoms compared to those who tested negative for SARS-CoV-2. Experiencing shivering and loss of smell may be the best indicators for increased likelihood of testing positive for SARS-CoV-2.

Keywords: COVID-19; SARS-CoV-2; loss of smell; mood; predictors; quality of life; sleep quality; symptoms.

PubMed Disclaimer

Conflict of interest statement

Over the past 3 years, J.V. has acted as a consultant/advisor for Eisai, KNMP, Med Solutions, Red Bull, Sen-Jam Pharmaceutical, and Toast! J.G. is part-time employee of Danone and received research grants from Nutricia research foundation, Top Institute Pharma, Top Institute Food and Nutrition, GSK, STW, NWO, Friesland Campina, CCC, Raak-Pro, and EU. P.K. is CEO of PanGenix. The other authors have no potential conflicts of interest to disclose.

Figures

Figure 1
Figure 1
Illustration of a COVID-19 test street. Participants who entered by car were tested while remaining in their car (A), while those who came by foot or bicycle were tested inside the test facility (B). The photos are used with permission from Lead Healthcare.
Figure 2
Figure 2
Severity ratings of COVID-19 symptoms that significantly differed between individuals who tested positive (P) or negative (N) for SARS-CoV-2.

Similar articles

References

    1. Ministerie van Volksgezondheid, Welzijn, en Sport Besluiten naar Aanleiding van OMT Advies 25 mei 2020. [(accessed on 20 January 2024)]. Available online: https://open.overheid.nl/documenten/ronl-739c3a75-a1bc-4083-9bf5-1d985e4....
    1. Centers for Disease Control and Prevention Symptoms of COVID-19. [(accessed on 1 November 2020)]; Available online: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html.
    1. Centers for Disease Control and Prevention About Rhinoviruses. [(accessed on 24 June 2024)]; Available online: https://www.cdc.gov/rhinoviruses/about/index.html.
    1. Centers for Disease Control and Prevention Flu Symptoms & Complications. [(accessed on 17 January 2024)]; Available online: https://www.cdc.gov/flu/symptoms/symptoms.htm.
    1. Martín-Sánchez V., Fernández-Villa T., Carvajal Urueña A., Rivero Rodríguez A., Reguero Celada S., Sánchez Antolín G., Fernández-Vázquez J.P. Role of Rapid Antigen Testing in Population-Based SARS-CoV-2 Screening. J. Clin. Med. 2021;10:3854. doi: 10.3390/jcm10173854. - DOI - PMC - PubMed

Publication types

Supplementary concepts